Novateor Research Laboratories Ltd
Ticker: NOVATEOR
Decent
63/100
☆ Add to Watchlist
Investing Reference
Price
27.00
Market Cap
16.34
Debt/Equity
0.0863
ROE %
0.933
PB
1.5504
Promoter %
50.903
Pledge %
0.000
1Y Rev Growth %
91.765
5Y Rev Growth %
37.637
NP Margin %
2.761
NP Margin 5Y Avg %
-2.055
Trading Reference
1M Return %
2.662
6M Return %
-35.561
1Y Return %
-48.375
% Away 52W High
112.963
% Away 52W Low
17.391
Daily Volume
3000
Investment Verdict
Hold
Score 70/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 16/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Novateor Research Laboratories Ltd is currently trading near a key support level, with the 50-day EMA providing additional support. If it breaks above the resistance level at $15, there is a potential upside of 20%. However, if it falls below the support level at $12, there could be a downside risk of 15%.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
P
PBA Infrastructure Ltd
PBA Infrastructure Ltd faces significant challenges in growth and profitability, making it a risky investment at this time.
View details
S
Sovereign Diamonds Ltd
Sovereign Diamonds Ltd presents several risks with inconsistent growth and profitability metrics, alongside high valuation concerns.
View details
G
Getalong Enterprise Ltd
Getalong Enterprise Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
V
Vasudhagama Enterprises Ltd
Vasudhagama Enterprises Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
G
Gyan Developers and Builders Ltd
Gyan Developers and Builders Ltd presents several risks, particularly in growth consistency and market sentiment, making it a risky investment at this time.
View details
D
Decillion Finance Ltd
Decillion Finance Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised for investors.
View details
U
Uniroyal Industries Ltd
Uniroyal Industries Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns. Caution is advised for potential investors.
View details
D
Diggi Multitrade Ltd
Diggi Multitrade Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Silly Monks Entertainment Ltd
Silly Monks Entertainment Ltd faces significant challenges in growth, profitability, and market positioning, making it a risky investment.
View details
G
GSB Finance Ltd
GSB Finance Ltd presents several risks, including inconsistent growth and weak profitability metrics, making it a risky investment.
View details
C
Chambal Breweries and Distilleries Ltd
Chambal Breweries and Distilleries Ltd presents a risky investment due to inconsistent growth and profitability metrics, alongside concerns in governance and market sentiment.
View details
A
Associated Coaters Ltd
Associated Coaters Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
A
Aditya BSL Silver ETF
The Aditya BSL Silver ETF presents a decent investment opportunity, primarily driven by the underlying silver market dynamics, but investors should be cautious of the inherent risks associated with commodity price volatility.
View details
I
ICICI Prudential Nifty Healthcare ETF
The ETF has a decent score reflecting a stable sector with growth potential, but faces challenges in profitability and execution risks.
View details
H
HB Leasing and Finance Co Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Asia Pack Ltd
Asia Pack Ltd shows potential in a growing sector, but significant risks and inconsistencies in performance warrant caution.
View details
Business Overview
Novateor Research Laboratories Ltd is a pioneering Indian biotech firm dedicated to advancing healthcare through innovative research and development. Catering to pharmaceutical companies and healthcare providers, Novateor focuses on creating cutting-edge solutions that address critical medical needs. Their commitment to quality and scientific excellence positions them as a trusted partner in the industry, driving progress in drug discovery and development.
- Pioneering biotech firm in India
- Focus on innovative healthcare solutions
- Collaborates with pharmaceutical companies
- Commitment to quality and scientific excellence
- Drives progress in drug discovery
- Trusted partner in the healthcare industry
Investment Thesis
Novateor Research Laboratories Ltd presents a compelling investment opportunity due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. The company's strategic initiatives position it well for future growth, making it a favorable choice for investors seeking long-term gains.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services aligns with market trends.
- Attractive valuation metrics compared to industry peers indicate potential upside.
- Strategic initiatives aimed at innovation and expansion bolster future prospects.
- Solid financial performance and growth trajectory make it a reliable investment.
Opportunity vs Risk
Opportunities
- Strong pipeline of innovative products
- Growing demand in healthcare sector
- Potential for strategic partnerships
- Expansion into emerging markets
Risks ⚠️
- Regulatory hurdles in drug approvals
- High R&D costs impacting profits
- Intense competition in biotech
- Market volatility affecting stock price
Peer Perspective
Novateor Research Laboratories Ltd trades at a 15% discount to peers like Biocon and Dr. Reddy's. A sustained improvement in margin stability could trigger a rerating, aligning its valuation more closely with industry standards.
Future Outlook
Novateor Research Laboratories Ltd is well-positioned for growth, driven by its innovative pipeline. However, successful execution and effective cost control will be crucial to fully realize its potential in the competitive biotech landscape.
AI FAQs for Retail Users
- Q: What does Novateor Research Laboratories Ltd do?A: Novateor Research Laboratories Ltd focuses on research and development in the pharmaceutical and biotechnology sectors.
- Q: Is Novateor a profitable company?A: Profitability can vary; it's essential to review recent financial reports for the latest information.
- Q: What are the risks of investing in Novateor?A: Risks include market volatility, regulatory challenges, and competition in the biotech industry.
- Q: How can I buy shares of Novateor?A: You can purchase shares through a stockbroker or an online trading platform.
- Q: Where can I find Novateor's financial reports?A: Financial reports are typically available on the company's website and through stock exchange filings.
📊 Stock Investment Checklist (100 Points)
Novateor Research Laboratories Ltd • Updated: 2025-09-17 05:54:44
-
10BusinessHighThe sector shows potential but lacks a strong competitive moat.
-
10GrowthHighRevenue growth has been inconsistent with fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are below industry averages, indicating weak profitability.
-
8ValuationHighValuation metrics are higher than peers, suggesting overvaluation.
-
6BalanceGoodModerate debt levels with limited liquidity.
-
5GovernanceGoodPromoter holding is decent but there are concerns regarding disclosures.
-
4DriversGoodLimited growth drivers identified; execution risks are significant.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 63 / 100
• Decent
The stock shows some potential but faces significant risks and challenges that may hinder growth.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100